Perioperative chemotherapy for muscle‐invasive bladder cancer: A population‐based outcomes study

BACKGROUND Practice guidelines recommend neoadjuvant chemotherapy (NACT) for bladder cancer. However, the evidence in support of adjuvant chemotherapy (ACT) is less robust. Here we describe whether the evidence of efficacy for NACT/ACT was sufficient to change clinical practice and whether the effic...

Ausführliche Beschreibung